Loading...
Amphenol Corp (APH) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company demonstrates strong financial growth, positive analyst sentiment, insider buying, and hedge fund interest, making it a solid choice for long-term investment.
The MACD is below 0 and negatively contracting, indicating a bearish trend. RSI is neutral at 52.177, showing no overbought or oversold conditions. Moving averages are converging, suggesting indecision in the market. Key support is at 129.867, and resistance is at 147.783, with the stock trading near the resistance level.

Hedge funds are significantly increasing their positions in the stock (542.48% increase in buying).
Insider buying by Director Robert Livingston, purchasing 10,000 shares for $1.29M, indicating confidence in the company's future.
Strong financial performance in Q4 2025, with revenue up 49.13% YoY and net income up 60.21% YoY.
Analysts have raised price targets, with multiple firms maintaining Buy or Overweight ratings.
The company has a record order book of $8.4B and is positioned for 30% annual earnings growth.
The MACD and technical indicators suggest a lack of strong upward momentum in the short term.
The stock recently sold off due to below-consensus Q1 sales guidance, although analysts view this as a conservative approach.
In Q4 2025, Amphenol reported revenue of $6.439B, up 49.13% YoY. Net income increased to $1.195B, up 60.21% YoY. EPS rose to $0.93, up 57.63% YoY. Gross margin improved to 38.22%, up 11.46% YoY. These figures indicate robust growth and operational efficiency.
Analysts are highly positive on APH, with multiple firms raising price targets and maintaining Buy or Overweight ratings. Price targets range from $165 to $210, with analysts citing strong growth, a record order book, and conservative guidance as reasons for optimism.